Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Serum Adropin, Salusin-α, Netrin-1, and Nesfatin-1 in Endometrioma and Their Association With Insulin Resistance

NCT04371133 is registered in ClinicalTrials.gov with Muğla Sıtkı Koçman University as lead sponsor.

NCT NCT04371133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04371133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Serum Adropin, Salusin-α, Netrin-1, and Nesfatin-1 in Endometrioma and Their Association With Insulin Resistance
Lead sponsor
Muğla Sıtkı Koçman University
Phase
Observational
Overall status
Completed
Start date
August 15, 2018
Completion date
March 15, 2020
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma, inflammation